Skip to main content

Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® Scanner

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SamanTree Medical
SamanTree MedicalSwitzerland - Lausanne
1 program
Histolog ScannerN/A1 trial
Active Trials
NCT07006090Recruiting5,000Est. Apr 2036

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
2030
2031
SamanTree MedicalHistolog Scanner

Clinical Trials (1)

Total enrollment: 5,000 patients across 1 trials

EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.

Start: Mar 2026Est. completion: Apr 20365,000 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 5,000 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.